Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1998-8-13
|
| pubmed:abstractText |
The currently used macrolide immunosuppressants, i.e., cyclosporine and tacrolimus, exert considerable nephrotoxicity. We aimed to avoid the nephrotoxic effects by applying a cyclosporine-free regimen for the induction as well as for the maintenance treatment of renal allograft recipients using mycophenolate mofetil (MMF) as the primary immunosuppressant.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
0041-1337
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
66
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
44-9
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:9679820-Acute Disease,
pubmed-meshheading:9679820-Adult,
pubmed-meshheading:9679820-Cyclosporine,
pubmed-meshheading:9679820-Female,
pubmed-meshheading:9679820-Graft Rejection,
pubmed-meshheading:9679820-Humans,
pubmed-meshheading:9679820-Immunosuppression,
pubmed-meshheading:9679820-Immunosuppressive Agents,
pubmed-meshheading:9679820-Male,
pubmed-meshheading:9679820-Middle Aged,
pubmed-meshheading:9679820-Mycophenolic Acid,
pubmed-meshheading:9679820-Retreatment
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients.
|
| pubmed:affiliation |
Division of Transplant Surgery, Klinikum Grosshadern, Ludwig-Maximilian-University, Munich, Germany. BernZanker@aol.com
|
| pubmed:publicationType |
Journal Article,
Clinical Trial
|